DBV Technologies S.A. - ADR

$13.50

up-down-arrow $-0.31 (-2.24%)

As on 31-Jul-2026 16:01EDT

Market cap

info icon

$799 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

5.1

Div. Yield

info icon

0 %

DBV Technologies S.A. - ADR Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 13.00 High: 13.73

52 Week Range

Low: 8.51 High: 26.19

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -1.4 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -2.1

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $2.7

  • EPSEPS information

    $-2.1

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    59,187,875

10 Years Aggregate

CFO

$-963.47 Mln

EBITDA

$-1,132.99 Mln

Net Profit

$-1,164.09 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
DBV Technologies S.A. - ADR
-29.6 -15.6 -33.5 43.7 -5.1 -23.6 -27.7
BSE Sensex
-7.8 1.8 0.8 -4.2 5.7 8.2 10.8
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 31-Jul-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
DBV Technologies S.A. - ADR
520.4 -67.3 -37.7 -4.4 -38.9 -75.5 66.7
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
DBV Technologies S.A. - ADR
13.5 799.0 0.0 -175.9 -- -106.8 -- 5.1
853.8 53,097.2 8,446.3 2,595.8 21.8 33 32.5 6.3
532.3 7,065.1 2,595.0 275.0 14.1 30.4 26.8 8.5
279.1 76,095.4 2,82,382.0 6,416.0 2.6 13.9 12.6 1.9
2.8 393.4 22,413.0 -300.0 19.4 -- 1.5 0.5
375.8 81,629.6 2,01,113.0 4,963.0 3.5 11.2 16.6 1.8
402.6 85,689.1 78,013.0 6,840.0 15.6 -- 13.7 291.3
363.9 43,692.4 1,45,679.0 1,278.0 1.6 6.8 34.6 2.3
6.7 1,195.3 2,489.5 -177.4 -6.4 -13.2 -- 1.2
414.4 3,82,755.6 4,50,129.0 14,122.0 4.8 13.6 31.6 3.9

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About DBV Technologies S.A. - ADR

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed...  Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France. 

Edit peer-selector-edit
loading...
loading...

FAQs for DBV Technologies S.A. - ADR

The share price of DBV Technologies SA - ADR is $13.50 (NASDAQ) as of 31-Jul-2026 16:01 EDT. DBV Technologies SA - ADR has given a return of -5.11% in the last 3 years.

Since, TTM earnings of DBV Technologies SA - ADR is negative, P/E ratio is not available.
The P/B ratio of DBV Technologies SA - ADR is 5.09 times as on 31-Jul-2026, a 8 premium to its peers’ median range of 4.71 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-9.99
8.70
2024
-0.52
2.17
2023
-1.26
0.65
2022
-1.49
0.74
2021
-0.90
0.89

The 52-week high and low of DBV Technologies SA - ADR are Rs 26.19 and Rs 8.51 as of 02-Aug-2026.

DBV Technologies SA - ADR has a market capitalisation of $ 799 Mln as on 31-Jul-2026. As per SEBI classification, it is a Small Cap company.

Before investing in DBV Technologies SA - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.